MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Stock Information for MacroGenics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MacroGenics Inc.

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.